Strategic Advocacy
The Strategic Advocacy division is comprised of several major policy divisions within the Chamber including the Cyber, Space, and National Security Division; Economic Policy Division; Employment Policy Division; and Small Business Policy Division. Environmental Affairs and Sustainability, Health Policy, and Transportation and Infrastructure Policy are also under the umbrella of the Policy Group.
The division works closely with the Chamber's Congressional and Public Affairs and Political Affairs and Federation Relations divisions.
Explore more
- Center for Global Regulatory Cooperation
- Cyber, Space, and National Security
- Economic Policy
- Employment Policy
- Environmental Affairs and Sustainability
- Global Initiative on Health and the Economy
- Government Affairs
- Health Policy
- Small Business Policy
- Tax Policy
- Transportation and Infrastructure Policy
- Federal Acquisition Council
Latest Content
- New petitions filed by Starbucks workers seek to get rid of their SEIU representation.This Hill letter was sent to the Members of the U.S. House of Representatives, supporting H.R. 1163, the "Protecting Taxpayers and Victims of Unemployment Fraud Act."This Statement for the Record was sent to the Members of the House Committee on Oversight & Accountability, for the hearing, "Costly Inaction on Federal Legacy IT."This Hill letter was sent to the Members of the House Committee on the Judiciary, opposing H.R. 3081, the “No Oil Producing and Exporting Cartels Act."The Teamsters Union is attempting to tell Amazon which contractors it should do business with.This Statement for the Record was sent to the Senate HELP Committee for the hearing, "The Need to Make Insulin Affordable for All Americans."The National Labor Relations Board issues contradictory orders and launches a preemptive strike against a free and fair election at Starbucks.U.S. Chamber of Commerce Will Award $25,000 to the WinnerThis Hill letter was sent to the Members of the Senate Committee on Health, Education, Labor and Pensions, on S. 1067, the "Ensuring Timely Access to Generics Act of 2023,” S. 1114, the “Expanding Access to Low-Cost Generics Act of 2023,” S. 1214, the “RARE Act,” and S. 1339, the “Pharmacy Benefit Manager Reform Act.”
